An Open-Label Extension Study of Levoketoconazole (2S, 4R ketoconazole) in the Treatment of the Endogenous Cushing’s Syndrome
Ente finanziatore
Cortendo AB
Aree / Gruppi di ricerca
Partecipanti al progetto
Descrizione del progetto
This is a multicenter study at approximately 50 sites in North America, Europe and the Middle East. The objective of this study is to assess long-term safety and efficacy durability of levoketoconazole as chronic treatment for endogenous Cushing’s Syndrome (CS).